iBio Inc [NASDAQ: IBIO] closed the trading session at $0.70.
The stocks have a year to date performance of -71.43 percent and weekly performance of -40.68 percent. The stock has been moved at -75.44 percent over the last six months. The stock has performed -84.88 percent around the most recent 30 days and changed -76.03 percent over the most recent 3-months.
If compared to the average trading volume of 638.13K shares, IBIO reached to a volume of 9144911 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about iBio Inc [IBIO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IBIO shares is $4.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IBIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for iBio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 28, 2024. While these analysts kept the previous recommendation, JMP Securities raised their target price to Mkt Outperform. The new note on the price target was released on November 29, 2021, representing the official price target for iBio Inc stock. Previously, the target price had yet another raise to $3, while Cantor Fitzgerald analysts kept a Overweight rating on IBIO stock.
The Average True Range (ATR) for iBio Inc is set at 0.39, with the Price to Sales ratio for IBIO stock in the period of the last 12 months amounting to 18.19. The Price to Book ratio for the last quarter was 0.46, with the Price to Cash per share for the same quarter was set at 0.71.
IBIO stock trade performance evaluation
iBio Inc [IBIO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -40.68. With this latest performance, IBIO shares dropped by -84.88% in over the last four-week period, additionally sinking by -75.44% over the last 6 months – not to mention a drop of -60.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IBIO stock in for the last two-week period is set at 17.41, with the RSI for the last a single of trading hit 10.05, and the three-weeks RSI is set at 24.02 for iBio Inc [IBIO]. The present Moving Average for the last 50 days of trading for this stock 3.7477, while it was recorded at 0.9035 for the last single week of trading, and 2.7262 for the last 200 days.
iBio Inc [IBIO]: An insightful look at the core fundamentals
iBio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.76 and a Current Ratio set at 1.76.
Earnings per share (EPS) analysis for iBio Inc [IBIO] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IBIO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for iBio Inc go to 45.01%.
iBio Inc [IBIO]: Institutional Ownership
There are presently around $26.65%, or 28.72%% of IBIO stock, in the hands of institutional investors.
